Vanguard Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,306,693
Closed -$312M 4541
2023
Q4
$312M Sell
5,306,693
-392,939
-7% -$23.1M 0.01% 1262
2023
Q3
$248M Buy
5,699,632
+721,357
+14% +$31.4M 0.01% 1320
2023
Q2
$180M Sell
4,978,275
-71,100
-1% -$2.57M ﹤0.01% 1518
2023
Q1
$188M Buy
5,049,375
+75,487
+2% +$2.81M ﹤0.01% 1482
2022
Q4
$225M Buy
4,973,888
+245,589
+5% +$11.1M 0.01% 1365
2022
Q3
$330M Buy
4,728,299
+180,278
+4% +$12.6M 0.01% 1072
2022
Q2
$305M Buy
4,548,021
+65,211
+1% +$4.38M 0.01% 1161
2022
Q1
$369M Buy
4,482,810
+43,833
+1% +$3.6M 0.01% 1169
2021
Q4
$651M Buy
4,438,977
+301,120
+7% +$44.2M 0.01% 842
2021
Q3
$732M Buy
4,137,857
+3,434
+0.1% +$608K 0.02% 768
2021
Q2
$668M Sell
4,134,423
-52,762
-1% -$8.52M 0.02% 818
2021
Q1
$717M Buy
4,187,185
+154,947
+4% +$26.5M 0.02% 758
2020
Q4
$886M Buy
4,032,238
+688,116
+21% +$151M 0.03% 621
2020
Q3
$555M Sell
3,344,122
-105,080
-3% -$17.4M 0.02% 732
2020
Q2
$394M Buy
3,449,202
+45,764
+1% +$5.22M 0.01% 867
2020
Q1
$262M Buy
3,403,438
+335,827
+11% +$25.8M 0.01% 971
2019
Q4
$395M Buy
3,067,611
+29,890
+1% +$3.85M 0.01% 952
2019
Q3
$237M Buy
3,037,721
+53,215
+2% +$4.15M 0.01% 1232
2019
Q2
$307M Buy
2,984,506
+802,468
+37% +$82.7M 0.01% 1086
2019
Q1
$160M Buy
2,182,038
+750,022
+52% +$55M 0.01% 1488
2018
Q4
$60.7M Buy
1,432,016
+111
+0% +$4.71K ﹤0.01% 1927
2018
Q3
$67.4M Buy
1,431,905
+26,316
+2% +$1.24M ﹤0.01% 1993
2018
Q2
$69.3M Buy
1,405,589
+387,198
+38% +$19.1M ﹤0.01% 1953
2018
Q1
$31.3M Sell
1,018,391
-1,523
-0.1% -$46.8K ﹤0.01% 2321
2017
Q4
$18.6M Buy
1,019,914
+60,107
+6% +$1.1M ﹤0.01% 2516
2017
Q3
$11.2M Buy
959,807
+308,390
+47% +$3.61M ﹤0.01% 2755
2017
Q2
$2.38M Sell
651,417
-33,698
-5% -$123K ﹤0.01% 3331
2017
Q1
$3.56M Buy
685,115
+161,303
+31% +$839K ﹤0.01% 3187
2016
Q4
$2.49M Sell
523,812
-227,885
-30% -$1.08M ﹤0.01% 3291
2016
Q3
$4.97M Buy
751,697
+127,653
+20% +$844K ﹤0.01% 3012
2016
Q2
$3.41M Buy
624,044
+67,729
+12% +$370K ﹤0.01% 3162
2016
Q1
$11.9M Buy
556,315
+22,424
+4% +$480K ﹤0.01% 2518
2015
Q4
$16.9M Buy
533,891
+113,467
+27% +$3.59M ﹤0.01% 2377
2015
Q3
$14.5M Buy
420,424
+127,662
+44% +$4.39M ﹤0.01% 2424
2015
Q2
$9.21M Buy
292,762
+14,208
+5% +$447K ﹤0.01% 2720
2015
Q1
$8.17M Buy
278,554
+62,538
+29% +$1.83M ﹤0.01% 2744
2014
Q4
$4M Buy
216,016
+1,658
+0.8% +$30.7K ﹤0.01% 3008
2014
Q3
$3.75M Buy
214,358
+4,260
+2% +$74.6K ﹤0.01% 2988
2014
Q2
$4.2M Buy
210,098
+16,848
+9% +$337K ﹤0.01% 2926
2014
Q1
$3.69M Buy
193,250
+14,069
+8% +$268K ﹤0.01% 2974
2013
Q4
$2.98M Buy
179,181
+157,449
+725% +$2.62M ﹤0.01% 3031
2013
Q3
$329K Buy
+21,732
New +$329K ﹤0.01% 3615